Gynecologic cancer researcher earns eighth retraction

Noriyuki Takai, a gynecologic cancer researcher in Japan, has notched one more retraction — bringing the total to eight — due to figures that were “processed inappropriately” and did “not accurately report the original data.” According to the notice, Takai alone put the figures together in the 2006 Oncology paper, which tested a histone deacetylase … Continue reading Gynecologic cancer researcher earns eighth retraction

Investigations into Voinnet’s work announced; critic publishes original peer review

The story about Olivier Voinnet, a high-profile plant biologist whose work has fallen under scrutiny, continues to build momentum. Late last week, Voinnet’s employer and one of his funders announced they were investigating his work, and one of the peer reviewers of a soon-to-be-retracted paper has made her original report public. Here’s the statement from … Continue reading Investigations into Voinnet’s work announced; critic publishes original peer review

JCI retracts paper by stem cell biologist Jacob Hanna, citing “figure irregularities”

The Journal of Clinical Investigation has retracted a 2004 paper by Jacob Hanna, a highly cited stem cell researcher in Israel whose work has been dogged by questions about its validity. Questions about the work, and other articles on which Hanna was an author, were raised on PubPeer last November. This is his first retraction. … Continue reading JCI retracts paper by stem cell biologist Jacob Hanna, citing “figure irregularities”

Wayne State neuroscientist fudged images in five papers

Teresita Briones, a former nursing professor at Wayne State University in Detroit who studied neuroscience, manipulated images in five papers, according to the Office of Research Integrity. Briones, who focused on neuroplasticity:

Retraction to appear for beleaguered plant researcher Olivier Voinnet

Olivier Voinnet, a researcher at ETH in Zurich who has corrected a number of his papers following critiques on PubPeer dating from late last year, is retracting a 2004 paper in The Plant Cell, according to the journal’s publisher. Voinnet, the winner of the 2013 Rössler Prize, is a high-profile scientist, and scrutiny of his work has only grown … Continue reading Retraction to appear for beleaguered plant researcher Olivier Voinnet

Cancer researcher under investigation in Italy notches eighth retraction

Alfredo Fusco, the researcher in Italy who is under criminal investigation and has had seven papers retracted, has lost yet another study. The investigation, which came to light in late 2013, had focused on eight papers thought to demonstrate evidence of image manipulation. The latest paper, in the European Journal of Cancer, studied mice with … Continue reading Cancer researcher under investigation in Italy notches eighth retraction

Weekend reads: Publication pollution, irreproducible research crisis, and broken funding models

The week at Retraction Watch featured an adventure in irony as a paper on plagiarism was retracted for…plagiarism, as well as another retraction for high-profile cancer research Robert Weinberg. Here’s what was happening elsewhere:

Cancer Cell issues big correction over “incorrectly cropped” figures, other issues

A 2014 Cancer Cell paper became the subject of an erratum in January 2015, shortly after PubPeer members began criticizing the data. However, many issues brought up by commenters weren’t addressed in the correction notice, including a figure that might be two experiments spliced together to look like one. The paper, led by Guido Franzoso at Imperial College … Continue reading Cancer Cell issues big correction over “incorrectly cropped” figures, other issues

Drug paper gets a fix, notching several corrections

The Journal of Materials Chemistry B has issued a laundry list of corrections for a 2014 chemotherapy paper, which address re-use of “some text”, incorrectly stated doses, and miscalculations of the drug concentration, among other issues. The paper described a new way to deliver gemcitabine via nanoparticles, focusing the drug on the tumors. It turns out the … Continue reading Drug paper gets a fix, notching several corrections

Weekend reads: Monsanto demands retraction; fast-track peer review for fee scrutinized; fraud in China

This week at Retraction Watch featured 43 papers retracted at once for fake peer reviews. Here’s what was happening elsewhere: